The link you have chosen leads to a site maintained by a third party over whom Bracco Imaging has no control. As such, Bracco Imaging makes no representation as to the accuracy or any other aspect of the information on this site. The clinical use of Bracco Imaging Products in these pages may not be consistent with the approved indications.
The information on this site is not country specific and may contain information that is outside the approved indication where you practice.
Please contact your local Bracco Imaging representative for the latest Bracco Imaging product information specific to your country.
2020
-
Monday, 27 April, 2020
Bracco Launches Global “BRACCO CARES” Initiative to Support Healthcare Professionals Through Trying Times -
Thursday, 30 January, 2020
Bracco named a 2020 Top Employer Italia
2019
-
Thursday, 27 June, 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics with the Acquisition of Blue Earth Diagnostics
2018
-
Tuesday, 31 July, 2018
Bracco Imaging collaborates with a major academic medical center on improving patient care through new protocols for Computed Tomography (CT) imaging -
Wednesday, 20 June, 2018
Kiina on hyväksynyt Braccon varjoaineen virtsateiden ultraäänitutkimuksissa käytettäväksi -
Tuesday, 22 May, 2018
Bracco Imaging ja Shanghai Pharmaceuticals yhdistyvät ultraäänimarkkinoilla -
Saturday, 3 March, 2018
Bracco Imaging vahvistaa portfoliotaan interventionalisessa onkologiassa -
Tuesday, 23 January, 2018
Bracco Imaging vahvistaa sitoutumistaan ultraääni-innovaatioihin
2017
-
Wednesday, 18 October, 2017
Bracco laajentaa toimintaansa fluoresenssilla ohjattuun kirurgiaan hankkimalla omistukseensa SurgVisionin -
Monday, 24 July, 2017
Public statement of Bracco Imaging with regard to the European Medicine Agency’s Final Opinion on Gadolinium-Based Contrast Agents -
Monday, 3 July, 2017
Bracco's Ultrasound Contrast Agent approved in the European Union for intravesical use in ultrasonography of the excretory tract -
Tuesday, 4 April, 2017
Bracco Imaging vahvistaa radiologian tietoteknistä portfoliotaan tekemällä strategisen investoinnin PHS Technologies Group –yritykseen. -
Saturday, 4 March, 2017
Bracco celebrates its 90th anniversary with the launch of the “Bracco Fellowships”, a new educational initiative for the development of young European radiologists
2016
-
Wednesday, 21 September, 2016
Bracco receives MHRA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Imaging of the whole body -
Thursday, 15 September, 2016
Bracco Imaging receives approval in Mexico for ultrasound contrast agent
2015
-
Wednesday, 3 June, 2015
Bracco Imaging announces the first echocardiography imaging procedure in US with sulfur hexafluoride lipid-type A microspheres for injectable suspension -
Thursday, 5 March, 2015
Bracco Imaging launches the EmpowerCTA®+
2014
-
Monday, 13 October, 2014
A new comparative study of non-ionic macrocyclic MRI contrast agents. -
Tuesday, 23 September, 2014
Bracco launches its Ultrasound Contrast Agent in Russia -
Thursday, 24 July, 2014
EIB Lends EUR 100 Million for Investment In Research And Innovation By Bracco Imaging -
Monday, 9 June, 2014
Bracco Announces Labeling Change for its Ultrasound Contrast Agent -
Monday, 28 April, 2014
Bracco Imaging expands its Global MRI franchise -
Thursday, 6 March, 2014
Bracco Imaging launches the new Tailored Protocol Software -
Wednesday, 5 March, 2014
Newly published breast MRI data at ECR2014
2013
-
Monday, 30 September, 2013
Bracco Imaging receives ANVISA approval in Brazil for ultrasound contrast agent -
Monday, 11 March, 2013
Bracco receives MHRA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Imaging of the breast -
Thursday, 7 March, 2013
MRI contrast agents compared at different doses
2012
-
Wednesday, 7 November, 2012
High-Concentration CT Contrast Media and Lower Radiation Dose -
Tuesday, 18 September, 2012
Bracco receives U.S. FDA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Angiography -
Thursday, 19 April, 2012
Bracco Imaging announces a new direct presence in Argentina, Brazil and Mexico -
Thursday, 1 March, 2012
Researchers find greater morphologic information and lesion enhancement with Bracco's MRI contrast agents
2011
-
Sunday, 27 November, 2011
RSNA: Bracco Imaging Continues its Investment in Delivering Radiological Solutions -
Monday, 1 August, 2011
Bracco Imaging acquires Swiss Medical Care -
Thursday, 3 March, 2011
ECR 2011 Press Releases
2010
-
Sunday, 28 November, 2010
Products, Services and Technologies Demonstrated at RSNA 2010 -
Thursday, 15 July, 2010
Two Researchers Awarded 2010 Bracco Diagnostics/RSNA Grants -
Thursday, 15 July, 2010
Diana Bracco: "Research & Innovation: the key to Italy's future"
2009
-
Friday, 27 March, 2009
Princeton, NJ, Court Rules that GE Healthcare Engaged in False Advertising Campaign against Bracco Diagnostics -
Friday, 6 March, 2009
Bracco Imaging attends ECR 2009 in Vienna and showcases expanded integrated imaging solutions portfolio
2008
-
Sunday, 30 November, 2008
Bracco Imaging showcased expanded portfolio, integrated solution set at RSNA 2008 -
Tuesday, 1 April, 2008
Merger of Bracco Diagnostics Inc. (BDI) with E-Z-EM enhances Bracco Group’s leadership in Diagnostic Imaging -
Friday, 7 March, 2008
Bracco Imaging gets closer to its European customers enlarging its direct presence in Germany, France, Belgium, Luxemburg, and the Netherlands.
2007
-
Sunday, 25 November, 2007
Bracco Diagnostics Inc. showcases its commitment to science and customers at RSNA 2007 -
Thursday, 8 November, 2007
Healthtrust Purchasing Group and Bracco Diagnostics Inc. sign three-year agreement for X-Ray Contrast Media -
Thursday, 8 November, 2007
Bracco Diagnostics Inc. receives 2007 Supplier Quality Award from Cardinal Health -
Tuesday, 30 October, 2007
Bracco Diagnostics Inc. to acquire E-Z-EM
